 | • レポートコード：QY2207C1492 • 出版社/出版日：QYResearch / 2022年7月8日 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：消費財 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の乳児用市販調製粉乳の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に乳児用市販調製粉乳の世界市場のxxx％を占める「牛乳タンパク質ベース調製粉乳」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「0〜6か月乳児」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の乳児用市販調製粉乳の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの乳児用市販調製粉乳市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの乳児用市販調製粉乳市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 乳児用市販調製粉乳のグローバル主要メーカーには、Nestle、Mead Johnson＆Company，LLC、Abbott、Feihe、Yili、Mengniu、Biostime、Beingmate、Synutra International Inc、Wondersun、Wissun、Shijiazhuang Junlebao Dairy Co., Ltd.、Brightdairy Dairy Co., Ltd、Sanyuan Group、Yinqiao Group、Longdan Dairyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 乳児用市販調製粉乳市場は、種類と用途によって区分されます。世界の乳児用市販調製粉乳市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 牛乳タンパク質ベース調製粉乳、大豆ベース調製粉乳、タンパク質加水分解物調製粉乳、その他 【用途別セグメント】 0〜6か月乳児、6〜12か月乳児、12〜24か月乳児、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 乳児用市販調製粉乳製品概要 - 種類別市場（牛乳タンパク質ベース調製粉乳、大豆ベース調製粉乳、タンパク質加水分解物調製粉乳、その他） - 用途別市場（0〜6か月乳児、6〜12か月乳児、12〜24か月乳児、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の乳児用市販調製粉乳販売量予測2017-2028 - 世界の乳児用市販調製粉乳売上予測2017-2028 - 乳児用市販調製粉乳の地域別販売量 - 乳児用市販調製粉乳の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別乳児用市販調製粉乳販売量 - 主要メーカー別乳児用市販調製粉乳売上 - 主要メーカー別乳児用市販調製粉乳価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（牛乳タンパク質ベース調製粉乳、大豆ベース調製粉乳、タンパク質加水分解物調製粉乳、その他） - 乳児用市販調製粉乳の種類別販売量 - 乳児用市販調製粉乳の種類別売上 - 乳児用市販調製粉乳の種類別価格 ・用途別市場規模（0〜6か月乳児、6〜12か月乳児、12〜24か月乳児、その他） - 乳児用市販調製粉乳の用途別販売量 - 乳児用市販調製粉乳の用途別売上 - 乳児用市販調製粉乳の用途別価格 ・北米市場 - 北米の乳児用市販調製粉乳市場規模（種類別、用途別） - 主要国別の乳児用市販調製粉乳市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの乳児用市販調製粉乳市場規模（種類別、用途別） - 主要国別の乳児用市販調製粉乳市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の乳児用市販調製粉乳市場規模（種類別、用途別） - 主要国別の乳児用市販調製粉乳市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の乳児用市販調製粉乳市場規模（種類別、用途別） - 主要国別の乳児用市販調製粉乳市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの乳児用市販調製粉乳市場規模（種類別、用途別） - 主要国別の乳児用市販調製粉乳市場規模（トルコ、サウジアラビア） ・企業情報 Nestle、Mead Johnson＆Company，LLC、Abbott、Feihe、Yili、Mengniu、Biostime、Beingmate、Synutra International Inc、Wondersun、Wissun、Shijiazhuang Junlebao Dairy Co., Ltd.、Brightdairy Dairy Co., Ltd、Sanyuan Group、Yinqiao Group、Longdan Dairy ・産業チェーン及び販売チャネル分析 - 乳児用市販調製粉乳の産業チェーン分析 - 乳児用市販調製粉乳の原材料 - 乳児用市販調製粉乳の生産プロセス - 乳児用市販調製粉乳の販売及びマーケティング - 乳児用市販調製粉乳の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 乳児用市販調製粉乳の産業動向 - 乳児用市販調製粉乳のマーケットドライバー - 乳児用市販調製粉乳の課題 - 乳児用市販調製粉乳の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Commercial Infant Formulas Market
Due to the COVID-19 pandemic, the global Commercial Infant Formulas market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Cow Milk Protein-based Formulas accounting for % of the Commercial Infant Formulas global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 0-6 Month Infant segment is altered to an % CAGR throughout this forecast period.
China Commercial Infant Formulas market size is valued at US$ million in 2021, while the US and Europe Commercial Infant Formulas are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Commercial Infant Formulas landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Commercial Infant Formulas include Nestle, Mead Johnson＆Company，LLC, Abbott, Feihe, Yili, Mengniu, Biostime, Beingmate and Synutra International Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Commercial Infant Formulas Scope and Segment
Commercial Infant Formulas market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Commercial Infant Formulas market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Cow Milk Protein-based Formulas
Soy-based Formulas
Protein Hydrolysate Formulas
Others
Segment by Application
0-6 Month Infant
6-12 Month Infant
12-24 Month Infant
Others
By Company
Nestle
Mead Johnson＆Company，LLC
Abbott
Feihe
Yili
Mengniu
Biostime
Beingmate
Synutra International Inc
Wondersun
Wissun
Shijiazhuang Junlebao Dairy Co., Ltd.
Brightdairy Dairy Co., Ltd
Sanyuan Group
Yinqiao Group
Longdan Dairy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Commercial Infant Formulas Product Introduction
1.2 Market by Type
1.2.1 Global Commercial Infant Formulas Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cow Milk Protein-based Formulas
1.2.3 Soy-based Formulas
1.2.4 Protein Hydrolysate Formulas
1.2.5 Others
1.3 Market by Application
1.3.1 Global Commercial Infant Formulas Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 0-6 Month Infant
1.3.3 6-12 Month Infant
1.3.4 12-24 Month Infant
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Commercial Infant Formulas Sales Estimates and Forecasts 2017-2028
2.2 Global Commercial Infant Formulas Revenue Estimates and Forecasts 2017-2028
2.3 Global Commercial Infant Formulas Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Commercial Infant Formulas Sales by Region
2.4.1 Global Commercial Infant Formulas Sales by Region (2017-2022)
2.4.2 Global Sales Commercial Infant Formulas by Region (2023-2028)
2.5 Global Commercial Infant Formulas Revenue by Region
2.5.1 Global Commercial Infant Formulas Revenue by Region (2017-2022)
2.5.2 Global Commercial Infant Formulas Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Commercial Infant Formulas Sales by Manufacturers
3.1.1 Global Top Commercial Infant Formulas Manufacturers by Sales (2017-2022)
3.1.2 Global Commercial Infant Formulas Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Commercial Infant Formulas in 2021
3.2 Global Commercial Infant Formulas Revenue by Manufacturers
3.2.1 Global Commercial Infant Formulas Revenue by Manufacturers (2017-2022)
3.2.2 Global Commercial Infant Formulas Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Commercial Infant Formulas Revenue in 2021
3.3 Global Commercial Infant Formulas Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Commercial Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Commercial Infant Formulas Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Commercial Infant Formulas Sales by Type
4.1.1 Global Commercial Infant Formulas Historical Sales by Type (2017-2022)
4.1.2 Global Commercial Infant Formulas Forecasted Sales by Type (2023-2028)
4.1.3 Global Commercial Infant Formulas Sales Market Share by Type (2017-2028)
4.2 Global Commercial Infant Formulas Revenue by Type
4.2.1 Global Commercial Infant Formulas Historical Revenue by Type (2017-2022)
4.2.2 Global Commercial Infant Formulas Forecasted Revenue by Type (2023-2028)
4.2.3 Global Commercial Infant Formulas Revenue Market Share by Type (2017-2028)
4.3 Global Commercial Infant Formulas Price by Type
4.3.1 Global Commercial Infant Formulas Price by Type (2017-2022)
4.3.2 Global Commercial Infant Formulas Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Commercial Infant Formulas Sales by Application
5.1.1 Global Commercial Infant Formulas Historical Sales by Application (2017-2022)
5.1.2 Global Commercial Infant Formulas Forecasted Sales by Application (2023-2028)
5.1.3 Global Commercial Infant Formulas Sales Market Share by Application (2017-2028)
5.2 Global Commercial Infant Formulas Revenue by Application
5.2.1 Global Commercial Infant Formulas Historical Revenue by Application (2017-2022)
5.2.2 Global Commercial Infant Formulas Forecasted Revenue by Application (2023-2028)
5.2.3 Global Commercial Infant Formulas Revenue Market Share by Application (2017-2028)
5.3 Global Commercial Infant Formulas Price by Application
5.3.1 Global Commercial Infant Formulas Price by Application (2017-2022)
5.3.2 Global Commercial Infant Formulas Price Forecast by Application (2023-2028)
6 North America
6.1 North America Commercial Infant Formulas Market Size by Type
6.1.1 North America Commercial Infant Formulas Sales by Type (2017-2028)
6.1.2 North America Commercial Infant Formulas Revenue by Type (2017-2028)
6.2 North America Commercial Infant Formulas Market Size by Application
6.2.1 North America Commercial Infant Formulas Sales by Application (2017-2028)
6.2.2 North America Commercial Infant Formulas Revenue by Application (2017-2028)
6.3 North America Commercial Infant Formulas Market Size by Country
6.3.1 North America Commercial Infant Formulas Sales by Country (2017-2028)
6.3.2 North America Commercial Infant Formulas Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Commercial Infant Formulas Market Size by Type
7.1.1 Europe Commercial Infant Formulas Sales by Type (2017-2028)
7.1.2 Europe Commercial Infant Formulas Revenue by Type (2017-2028)
7.2 Europe Commercial Infant Formulas Market Size by Application
7.2.1 Europe Commercial Infant Formulas Sales by Application (2017-2028)
7.2.2 Europe Commercial Infant Formulas Revenue by Application (2017-2028)
7.3 Europe Commercial Infant Formulas Market Size by Country
7.3.1 Europe Commercial Infant Formulas Sales by Country (2017-2028)
7.3.2 Europe Commercial Infant Formulas Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Commercial Infant Formulas Market Size by Type
8.1.1 Asia Pacific Commercial Infant Formulas Sales by Type (2017-2028)
8.1.2 Asia Pacific Commercial Infant Formulas Revenue by Type (2017-2028)
8.2 Asia Pacific Commercial Infant Formulas Market Size by Application
8.2.1 Asia Pacific Commercial Infant Formulas Sales by Application (2017-2028)
8.2.2 Asia Pacific Commercial Infant Formulas Revenue by Application (2017-2028)
8.3 Asia Pacific Commercial Infant Formulas Market Size by Region
8.3.1 Asia Pacific Commercial Infant Formulas Sales by Region (2017-2028)
8.3.2 Asia Pacific Commercial Infant Formulas Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Commercial Infant Formulas Market Size by Type
9.1.1 Latin America Commercial Infant Formulas Sales by Type (2017-2028)
9.1.2 Latin America Commercial Infant Formulas Revenue by Type (2017-2028)
9.2 Latin America Commercial Infant Formulas Market Size by Application
9.2.1 Latin America Commercial Infant Formulas Sales by Application (2017-2028)
9.2.2 Latin America Commercial Infant Formulas Revenue by Application (2017-2028)
9.3 Latin America Commercial Infant Formulas Market Size by Country
9.3.1 Latin America Commercial Infant Formulas Sales by Country (2017-2028)
9.3.2 Latin America Commercial Infant Formulas Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Commercial Infant Formulas Market Size by Type
10.1.1 Middle East and Africa Commercial Infant Formulas Sales by Type (2017-2028)
10.1.2 Middle East and Africa Commercial Infant Formulas Revenue by Type (2017-2028)
10.2 Middle East and Africa Commercial Infant Formulas Market Size by Application
10.2.1 Middle East and Africa Commercial Infant Formulas Sales by Application (2017-2028)
10.2.2 Middle East and Africa Commercial Infant Formulas Revenue by Application (2017-2028)
10.3 Middle East and Africa Commercial Infant Formulas Market Size by Country
10.3.1 Middle East and Africa Commercial Infant Formulas Sales by Country (2017-2028)
10.3.2 Middle East and Africa Commercial Infant Formulas Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Nestle
11.1.1 Nestle Corporation Information
11.1.2 Nestle Overview
11.1.3 Nestle Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Nestle Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nestle Recent Developments
11.2 Mead Johnson＆Company，LLC
11.2.1 Mead Johnson＆Company，LLC Corporation Information
11.2.2 Mead Johnson＆Company，LLC Overview
11.2.3 Mead Johnson＆Company，LLC Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Mead Johnson＆Company，LLC Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mead Johnson＆Company，LLC Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 Feihe
11.4.1 Feihe Corporation Information
11.4.2 Feihe Overview
11.4.3 Feihe Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Feihe Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Feihe Recent Developments
11.5 Yili
11.5.1 Yili Corporation Information
11.5.2 Yili Overview
11.5.3 Yili Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Yili Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yili Recent Developments
11.6 Mengniu
11.6.1 Mengniu Corporation Information
11.6.2 Mengniu Overview
11.6.3 Mengniu Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mengniu Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mengniu Recent Developments
11.7 Biostime
11.7.1 Biostime Corporation Information
11.7.2 Biostime Overview
11.7.3 Biostime Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biostime Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biostime Recent Developments
11.8 Beingmate
11.8.1 Beingmate Corporation Information
11.8.2 Beingmate Overview
11.8.3 Beingmate Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Beingmate Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Beingmate Recent Developments
11.9 Synutra International Inc
11.9.1 Synutra International Inc Corporation Information
11.9.2 Synutra International Inc Overview
11.9.3 Synutra International Inc Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Synutra International Inc Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Synutra International Inc Recent Developments
11.10 Wondersun
11.10.1 Wondersun Corporation Information
11.10.2 Wondersun Overview
11.10.3 Wondersun Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Wondersun Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wondersun Recent Developments
11.11 Wissun
11.11.1 Wissun Corporation Information
11.11.2 Wissun Overview
11.11.3 Wissun Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Wissun Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Wissun Recent Developments
11.12 Shijiazhuang Junlebao Dairy Co., Ltd.
11.12.1 Shijiazhuang Junlebao Dairy Co., Ltd. Corporation Information
11.12.2 Shijiazhuang Junlebao Dairy Co., Ltd. Overview
11.12.3 Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shijiazhuang Junlebao Dairy Co., Ltd. Recent Developments
11.13 Brightdairy Dairy Co., Ltd
11.13.1 Brightdairy Dairy Co., Ltd Corporation Information
11.13.2 Brightdairy Dairy Co., Ltd Overview
11.13.3 Brightdairy Dairy Co., Ltd Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Brightdairy Dairy Co., Ltd Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Brightdairy Dairy Co., Ltd Recent Developments
11.14 Sanyuan Group
11.14.1 Sanyuan Group Corporation Information
11.14.2 Sanyuan Group Overview
11.14.3 Sanyuan Group Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sanyuan Group Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sanyuan Group Recent Developments
11.15 Yinqiao Group
11.15.1 Yinqiao Group Corporation Information
11.15.2 Yinqiao Group Overview
11.15.3 Yinqiao Group Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Yinqiao Group Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Yinqiao Group Recent Developments
11.16 Longdan Dairy
11.16.1 Longdan Dairy Corporation Information
11.16.2 Longdan Dairy Overview
11.16.3 Longdan Dairy Commercial Infant Formulas Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Longdan Dairy Commercial Infant Formulas Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Longdan Dairy Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Commercial Infant Formulas Industry Chain Analysis
12.2 Commercial Infant Formulas Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Commercial Infant Formulas Production Mode & Process
12.4 Commercial Infant Formulas Sales and Marketing
12.4.1 Commercial Infant Formulas Sales Channels
12.4.2 Commercial Infant Formulas Distributors
12.5 Commercial Infant Formulas Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Commercial Infant Formulas Industry Trends
13.2 Commercial Infant Formulas Market Drivers
13.3 Commercial Infant Formulas Market Challenges
13.4 Commercial Infant Formulas Market Restraints
14 Key Findings in The Global Commercial Infant Formulas Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer